Month: December 2023

Enlarge / This picture, taken several months ago, shows different parts for Blue Origin's New Glenn rocket inside the company's manufacturing facility in Florida. (credit: Blue Origin)

For the first time, it's starting to feel like Jeff Bezos's space company, Blue Origin, might have a shot at launching its long-delayed New Glenn rocket within the next 12 months.

Of course, there's a lot for Blue Origin to test and validate before New Glenn is ready to fly. First, the company's engineers need to fully assemble a New Glenn rocket and raise it on the company's sprawling seaside launch pad at Cape Canaveral Space Force Station in Florida. There's a good chance of this happening in the coming months as Blue Origin readies for a series of tanking tests and simulated countdowns at the launch site.

It's tempting to invoke Berger's Law, the guideline championed by my Ars colleague which states that if a launch is scheduled for the fourth quarter of a calendar year—and if it is at least six months away—the launch will delay into the next year. Given Blue Origin's history of New Glenn delays, that's probably the safer bet. New Glenn's inaugural flight has been delayed from 2020 until 2021, then 2022, and for now, is slated for 2024.

Enlarge / This photo is exactly what it was like to be on the E3 show floor. Exactly. (credit: Aurich Lawson | Getty Images)

Today's news that the Electronic Entertainment Expo is officially, totally, and completely dead was a bit bittersweet for your humble Ars Technica Senior Gaming Editor. Don't get me wrong, I'll miss the chance to meet industry luminaries, connect with far-flung associates, and play games months ahead of time in a setting that's as much a theme park as a trade show. But after spending many a late night covering 15 E3 shows in 16 years, I can say that the crowds, the smells, and the sensory overload associated with the LA Convention Center aren't always all they're cracked up to be.

Still, those who have been there will tell you that, for a gaming fan, there was nothing quite like the bombast and spectacle of the E3 show floor in its heyday.

For those who haven't been there, we've sorted through literally hundreds of E3 photos taken by Ars journalists over the years to assemble a few dozen of the best into this visual travelogue-meets-history-lesson. We hope that skimming through the galleries below will give you some idea of the madcap event that E3 was and why it has generated so many lasting memories for those who attended.

Enlarge (credit: Getty | UniversalImagesGroup)

This year has been marked by many terrifying things, but perhaps the most surprising of the 2023 horrors was … eye drops.

The seemingly innocuous teeny squeeze bottle made for alarming headlines numerous times during our current revolution around the sun, with lengthy lists of recalls, startling factory inspections, and ghastly reports of people developing near-untreatable bacterial infections, losing their eyes and vision, and dying.

Recapping this unexpected threat to health, the Food and Drug Administration on Tuesday released an advisory titled "What You Should Know about Eye Drops" in hopes of keeping the dangers of this year from leaking into the next. Among the notable points from the regulator was this stark pronouncement: No one should ever use any homeopathic ophthalmic products, and every single such product should be pulled off the market.

We didn't get to see Dune: Part Two—the second film in director Denis Villeneuve's stunning adaptation of Frank Herbert's sci-fi classic—last month as originally planned since the film's November release was delayed until next March due to the Hollywood strikes. But Warner Bros. doesn't want us to completely forget about Dune in the meantime, so it dropped another trailer for the holiday season.

(Spoilers for Dune: Part One below.)

As reported previously (also here and here), Herbert's novel Dune is set in the distant future and follows the fortunes of various noble houses in what amounts to a feudal interstellar society. Much of the action takes place on the planet Arrakis, where the economy is driven largely by a rare, life-extending drug called melange ("the spice"). Melange also conveys a kind of prescience and makes faster-than-light travel practical. There's betrayal, a prophecy concerning a messianic figure, giant sandworms, and battle upon battle as protagonist Paul Atreides (Timothée Chalamet) contends with rival House Harkonnen and strives to defeat the forces of Shaddam IV, Emperor of the Known Universe.

Enlarge (credit: Getty)

Broadcom has moved forward with plans to transition VMware, a virtualization and cloud computing company, into a subscription-based business. As of December 11, it no longer sells perpetual licenses with VMware products. VMware, whose $61 billion acquisition by Broadcom closed in November, also announced on Monday that it will no longer sell support and subscription (SnS) for VMware products with perpetual licenses. Moving forward, VMware will only offer term licenses or subscriptions, according to its VMware blog post.

VMware customers with perpetual licenses and active support contracts can continue using them. VMware "will continue to provide support as defined in contractual commitments," Krish Prasad, senior vice president and general manager for VMware's Cloud Foundation Division, wrote. But when customers' SnS terms end, they won't have any support.

Broadcom hopes this will force customers into subscriptions, and it's offering "upgrade pricing incentives" that weren't detailed in the blog for customers who switch from perpetual licensing to a subscription.